首页 › 基金 › Trails Edge Capital Partners, LP › FTH
Trails Edge Capital Partners, LP 对 FTH 的持仓历史
FAETH THERAPEUTICS INC
Trails Edge Capital Partners, LP 在 Q3 2026 的 13F 申报中披露持有 FTH(FAETH THERAPEUTICS INC)941,689 股,市值约 US$28.0M,约占其申报组合的 4.02%,在其申报持仓中市值排名第 10 位。 Trails Edge Capital Partners, LP 最近 3 个申报季度中有 3 个季度披露了 FTH 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Trails Edge Capital Partners, LP 对 FTH 的持仓演变
Trails Edge Capital Partners, LP 于 Q1 2026 首次披露 FTH 持仓:125,000 股(约 US$3.9M)。 该持仓在 Q3 2026 达到峰值 941,689 股,市值约 US$28.0M。 在 3 次申报中,Trails Edge Capital Partners, LP 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 941,689 股、市值约 US$28.0M,环比增持 426,354 股。。 持仓曾出现大幅变动:Q2 2026 增持约 312% (随后一个季度股价上涨 19%)、Q3 2026 增持约 83% (随后一个季度股价下跌 66%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 125.00K | $3.94M | 新进 |
| Q2 2026 | 515.34K | $12.88M | 增持 |
| Q3 2026 | 941.69K | $28.01M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 FTH 与 13F 数据
FTH(FAETH THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 72 只申报持有 FTH,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$50.5M), Avoro Capital Advisors LLC (US$41.9M), BAKER BROS. ADVISORS LP (US$32.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 FTH 的基金
- MONTANOVA CAPITAL, LLC 2.02M 股 · $50.50M · Q2 2026
- Avoro Capital Advisors LLC 1.41M 股 · $41.93M · Q3 2026
- BAKER BROS. ADVISORS LP 1.29M 股 · $32.16M · Q2 2026
- Vivo Capital, LLC 844.58K 股 · $25.12M · Q3 2026
- B Group, Inc. 610.17K 股 · $18.15M · Q3 2026
- Fairmount Funds Management LLC 722.02K 股 · $18.05M · Q2 2026
- Caligan Partners LP 629.47K 股 · $15.74M · Q2 2026
- STEMPOINT CAPITAL LP 404.92K 股 · $12.04M · Q3 2026
- Octagon Capital Advisors LP 361.01K 股 · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M 股 · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K 股 · $4.51M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 124.10K 股 · $3.69M · Q3 2026
更多关于 Trails Edge Capital Partners, LP
常见问题
How long has Trails Edge Capital Partners, LP held FTH?
Trails Edge Capital Partners, LP has disclosed FTH holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Trails Edge Capital Partners, LP's current position in FTH?
As of Q3 2026, Trails Edge Capital Partners, LP holds 941.69K shares of FTH (FAETH THERAPEUTICS INC), valued at $28.01M, representing 4.02% of its reported portfolio and ranking #10.
Has Trails Edge Capital Partners, LP been buying or selling FTH?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP increased its position in FTH. The position peaked in Q3 2026 at 941.69K shares.
Which other funds hold FTH?
Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.